2024 STATUS List: 50 life sciences leaders

The list features those shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech.

February 27, 2024 Check out STAT+

Sponsored By

Introducing the 2024 STATUS List, the definitive accounting of leaders in the life sciences The 2024 STATUS List recognizes standout individuals in health, medicine, and the life sciences whose work has advanced those fields. By STAT Staff STAT+ | Experts say scale of Change cyberattack shows risk of centralized claims processing Change Health connects 900,000 physicians, 33,000 pharmacies, and 5,500 hospitals. Security experts say concentrated services present concentrated risks. By Brittany Trang and Tara Bannow and Bob Herman STAT+ | Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines Shares of the San Diego company more than doubled in premarket trading on the news of the successful Phase 2 study. By Andrew Joseph Anna Moneymaker/Getty Images STAT+ | FDA protocols originally intended to be extra conservative are now heralded as evidence of mifepristone's risk Cautious protocols adopted 20 years ago by the FDA in its approval of the abortion pill are now being touted as evidence of its dangers. By Olivia Goldhill STAT+ | FTC says pharmacy benefit managers are stonewalling requests for information The delay angered U.S. Sen. Chuck Grassley (R-Iowa), who has been pushing to change pharmacy benefit manager business practices. By Ed Silverman Opinion: Palliative psychiatry offers a new path for some people with serious mental illness Canada may implement "medical aid in dying" for some with serious mental illness. Palliative psychiatry is a lifesaving alternative. By Anand Kumar Illustration: STAT; Courtesy: Allen Goldberg Opinion: IVF bans like Alabama's could cost the lives of children already born Families rely on IVF and pre-implantation genetic diagnosis to prevent disease and save lives. That's under threat in Alabama. By Allen Goldberg

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser